These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12089100)

  • 1. Alteplase for stroke. Uncertainty remains about efficacy.
    Mann H
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12089100
    [No Abstract]   [Full Text] [Related]  

  • 2. Alteplase for acute stroke revisited: the first 10 years.
    Lyden PD; Lees KR; Davis SM
    Lancet Neurol; 2006 Sep; 5(9):722-4. PubMed ID: 16914399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 4. Alteplase for stroke. Patients and doctors are being misled by promotional pressures.
    Li J; Nathanson LA; Mills TJ; Netland KE; Paula R; Ragland D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092605
    [No Abstract]   [Full Text] [Related]  

  • 5. Alteplase for ischaemic stroke--much sooner is much better.
    Saver JL; Levine SR
    Lancet; 2010 May; 375(9727):1667-8. PubMed ID: 20472152
    [No Abstract]   [Full Text] [Related]  

  • 6. Alteplase for stroke. Why were these authors of the commentaries chosen?
    Hoffman JR
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092608
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteplase for stroke. Financial information is needed to ensure objectivity.
    Solomon RC
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092607
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteplase for stroke. American Heart Association explains how guidelines were formulated.
    Faxon D
    BMJ; 2002 Jun; 324(7353):1581; author reply 1581. PubMed ID: 12092606
    [No Abstract]   [Full Text] [Related]  

  • 10. Alteplase for acute ischemic stroke.
    Gonzales NR; Grotta JC
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):301-18. PubMed ID: 16716092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can the therapeutic window for tissue plasminogen activator be extended to 6 hours after stroke onset?
    Alexandrov AV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):342-3. PubMed ID: 16265558
    [No Abstract]   [Full Text] [Related]  

  • 12. A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke.
    Kasner SE; Levine SR
    Lancet Neurol; 2010 Sep; 9(9):843-5. PubMed ID: 20667791
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. tPA for acute stroke: balancing baseline imbalances.
    Mann J
    CMAJ; 2002 Jun; 166(13):1651-2; author reply 1652-3. PubMed ID: 12126317
    [No Abstract]   [Full Text] [Related]  

  • 15. Alteplase is safe to use within existing treatment guidelines, says independent review.
    Torjesen I
    BMJ; 2015 Jul; 351():h4062. PubMed ID: 26215777
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined stroke trial data confirms that early treatment with thrombolytics improves outcomes.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Apr; 15(7):8-9. PubMed ID: 15101394
    [No Abstract]   [Full Text] [Related]  

  • 17. Human recombinant tissue-plasminogen activator (alteplase): why not use the 'human' dose for stroke studies in rats?
    Haelewyn B; Risso JJ; Abraini JH
    J Cereb Blood Flow Metab; 2010 May; 30(5):900-3. PubMed ID: 20216551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 19. Doubling in use of alteplase in Australia between 2003 and 2009.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Int J Stroke; 2014 Aug; 9(6):E28. PubMed ID: 25043521
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of tissue plasminogen activator to treat acute ischemic stroke.
    Alexandrov AW
    Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.